Spitzoid cutaneous melanoma is associated with favorable clinicopathological factors and outcome

J Cosmet Dermatol. 2019 Dec;18(6):1841-1845. doi: 10.1111/jocd.12958. Epub 2019 Apr 23.

Abstract

Background: Spitzoid melanoma is one of the rare subtypes of melanoma, whose clinical and pathological characteristics have yet to be understood.

Objective: Understanding the histopathologic features and behavior characteristics of Spitzoid cutaneous melanoma.

Methods: A total number of 11 Turkish Caucasian patients with pathologically diagnosed Spitzoid melanoma were analyzed retrospectively.

Results: The median age of patients was 24 years (ranging from 16 to 54 years), and the females outnumbered the males (90%). The extremities, especially lower limbs (67%), were the most commonly affected primary areas (64% of patients). Median depth and mitotic rate were 2.2 mm and 3 /mm2 , respectively. The presence of ulceration and regression were observed in a few lesions (14%). While tumor-infiltrating lymphocytes were expressed in all of the lesions, none of the lesions was associated with lymphovascular invasion and/or neurotropism. The regional lymph nodes were involved only in minority of the patients (27%), and no patients had metastatic disease. Recurrences occurred in only two patients (18%) that affected merely distant areas, that is, lung and brain. The median disease-free survival time and 5-year disease-free survival rate were 20.5 months and 80.6%, respectively. Only one (9%) death occurred; and the median overall survival time was 26.2 months, and 5-year overall survival rate was 90.7%.

Conclusion: Spitzoid cutaneous melanoma is correlated with favorable histopathologic and clinical characteristics, and therefore, it is associated with better survival rates.

Keywords: Spitzoid melanoma; prognosis; survival.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Humans
  • Male
  • Melanoma / mortality
  • Melanoma / pathology*
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology*
  • Survival Rate
  • Young Adult